EM

Ernie Yap M.D.

Medical Director at Aurinia Pharmaceuticals

Ernie Yap, MD has a diverse background in the medical field. Ernie is currently working as a Medical Director for Aurinia Pharmaceuticals Inc. since 2022. Prior to this, they served as a Clinical Assistant Professor of Medicine and Nephrologist at SUNY Downstate Medical Center from 2017 to 2022. Ernie also worked as a Physician at the National University of Malaysia from 2013 to 2017.

In addition to their medical roles, Dr. Yap has experience in medical writing as a Medical Science Writer at South China Morning Post in 2012. Ernie also worked as an Internal Medicine Hospitalist at Rogue Valley Medical Center from 2012 to 2013 and as an Internal Medicine Physician at Aspirus Grandview from 2011 to 2012.

Dr. Yap began their medical career as a Resident Physician at New York Presbyterian Hospital from 2008 to 2011. Overall, their experience spans various aspects of medicine, including clinical practice, research, teaching, and leadership.

Ernie Yap, MD completed their Doctor of Medicine (MD) degree at Dalhousie University from 2005 to 2008, with a focus on Medicine. Ernie then pursued further education and training by completing a Fellowship in Nephrology at SUNY Downstate Health Sciences University from 2017 to 2019. Prior to their Fellowship, Dr. Yap engaged in a program affiliated with The New York Hospital Queens and Weill Medical College of Cornell University from 2008 to 2011, specializing in Internal Medicine. Ernie holds certifications in Internal Medicine from the American Board of Internal Medicine, obtained in November 2011, and Subspecialty Certification in Nephrology, obtained in November 2019. Dr. Yap also obtained additional certification in GCP for Clinical Trials with Investigational Drugs and Medical Devices (U.S. FDA Focus) from the CITI Program, a Division of BRANY in April 2021.

Links

Previous companies

NewYork-Presbyterian logo
South China Morning Post logo
SUNY Downstate Medical Center logo

Timeline

  • Medical Director

    March, 2022 - present

View in org chart